A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.
The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.
NBC News on MSN12d
FDA approves new type of nonopioid painkiller for acute painThe drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.
Acute and chronic postoperative pain and functional disability persisted among patients who underwent posterior spinal fusion despite multimodal analgesic management.
The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side effects.
Patients who experience musculoskeletal pain have many pharmaceutical options for relief — unless they also suffer from ...
Ibuprofen, a common painkiller, is found to boost memory and intelligence in a University College London study. While some ...
New drugs like suzetrigine should be tried ... at reducing pain after 12 weeks — but it is common for doctors to prescribe acute pain medications off-label for chronic pain.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results